Amr M. Fahmi: Genotype-Guided Warfarin Dosing in the Arab Population
Amr M. Fahmi, Clinical Pharmacist at Hamad Medical Corporation, Adjunct Clinical Instructor at Qatar University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Clinical and Applied Thrombosis/Hemostasis, adding:
“I am delighted to share our publication where we derived and validated a genotype guided warfarin dosing algorithm in the Arab population.
With a sample of more than 400 patients, the new algorithm had better precision compared to Gage et Al. in the studied population.”
Title: Derivation and Validation of a Genotype – Guided Warfarin Dosing Model in a Mixed Arab Population
Authors: Amr M Fahmi, Ahmed El Bardissy, Mohamed Omar Saad, Islam Eljilany, Loulia Bader, Hazem Elewa
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 21, 2026, 15:17Leveraging Data to Drive Sustainable Care for Haemophilia and Haemoglobinopathies – NNHF
-
Aug 21, 2026, 15:04Sex Differences in Platelet Function in Type 2 Diabetes – Seminars in Thrombosis and Hemostasis
-
Aug 21, 2026, 15:04Parth Parmar: RBC Morphology – A Practical Guide to Blood Smear Interpretation
-
Aug 21, 2026, 14:32Kenneth Nollet: Building the Future of Transfusion Laboratory Science
-
Aug 21, 2026, 14:14Tareq Abadl: A Positive Antibody Screen is Not The Diagnosis
-
Aug 21, 2026, 14:08Katrina Snow։ Transfusion Trends and Quality Improvement in Sickle Cell Disease
-
Aug 21, 2026, 14:00Rucha Patil: The Power of Point-of-Care Testing in Hemostasis
-
Aug 21, 2026, 13:56Sarah Kowalski։ Supporting the Next Generation of Transfusion Laboratory Scientists
-
Aug 21, 2026, 13:51Join EHC 2026 Annual Conference